Fully differential topologies are well-suited for biopotential
amplifiers, mainly for single-supply battery-powered circuits such as
portable wearable devices where a reduced number of parts is desired. A
novel fully differential biopotential amplifier is proposed with the
goal of providing electrode offset rejection, bandwidth limitation, and
a temporal response compliant with biomedical standards with only a
single commercial quad operational amplifier (OA) integrated circuit.